Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hepatitis B virus.

J L Brown, W F Carman, H C Thomas

    Bailliere'S Clinical Gastroenterology
    |September 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Hepatitis B virus (HBV) causes significant global illness and death. New PCR methods reveal inaccuracies in older serological interpretations, highlighting the need for better diagnostics and treatments for chronic HBV infection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.

    Journal of viral hepatitis·2016
    Same author

    Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency.

    Metabolic brain disease·2014
    Same author

    Successful control of nosocomial transmission of the USA300 clone of community-acquired meticillin-resistant Staphylococcus aureus in a UK paediatric burns centre.

    The Journal of hospital infection·2013
    Same author

    Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation.

    Journal of viral hepatitis·2012
    Same author

    A comparison of 31P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease.

    Journal of viral hepatitis·2011
    Same author

    The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.

    Journal of viral hepatitis·2011

    Area of Science:

    • Hepatology and Virology
    • Immunology and Infectious Diseases

    Background:

    • Hepatitis B virus (HBV) is a leading cause of global morbidity and mortality due to its transmissibility and potential for chronic infection, leading to cirrhosis and hepatocellular carcinoma.
    • Previous interpretations of serological data for HBV infection are being revised with the advent of Polymerase Chain Reaction (PCR) technology.
    • Detectable HBV DNA is found in patients with anti-HBe and anti-HBs, and even in some hepatocellular carcinoma cases lacking serological markers, indicating complex viral persistence.

    Purpose of the Study:

    • To review the current understanding of HBV infection, including diagnostic challenges, host immune responses, and therapeutic strategies.
    • To highlight the evolving interpretation of serological markers in light of PCR findings.
    • To discuss the role of immune responses and potential interventions for managing HBV.

    Related Experiment Videos

    Main Methods:

    • Review of existing literature on HBV serology, PCR detection of HBV DNA, and host immune responses (interferon system, cytotoxic T cells, humoral immunity).
    • Analysis of clinical data regarding the effectiveness of immunization, immune stimulation, and antiviral chemotherapy.
    • Consideration of emerging findings, such as pre-core region mutations in HBV isolates.

    Main Results:

    • PCR has revealed that some patients with apparent serological resolution of HBV still harbor detectable viral DNA.
    • Host immune clearance of HBV-infected cells involves interferon and cellular immunity, with nucleocapsid proteins and pre-S sequences as key targets.
    • Alpha-interferon therapy achieves HBe antigen clearance in 40-60% of adults with chronic HBV, leading to reduced hepatic inflammation.

    Conclusions:

    • Accurate interpretation of HBV infection requires advanced diagnostics like PCR, as serological markers alone can be misleading.
    • Effective management of HBV involves a multi-pronged approach including immunization, immune stimulation, and antiviral therapies tailored to different patient populations.
    • Further research into HBV uptake mechanisms, in vitro models, and the role of viral mutants is crucial for developing improved treatments and prevention strategies.